CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 261 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $337,574 | -13.0% | 28,877 | -0.2% | 0.01% | -6.7% |
| Q2 2023 | $388,000 | +59.0% | 28,942 | +96.7% | 0.02% | +50.0% |
| Q1 2023 | $244,000 | -11.3% | 14,715 | -0.7% | 0.01% | -9.1% |
| Q4 2022 | $275,000 | -79.9% | 14,818 | -93.8% | 0.01% | -75.0% |
| Q2 2021 | $1,370,000 | +24.7% | 238,281 | -0.1% | 0.04% | +18.9% |
| Q1 2021 | $1,099,000 | +37.5% | 238,489 | -0.3% | 0.04% | +37.0% |
| Q4 2020 | $799,000 | -8.3% | 239,292 | -18.4% | 0.03% | -15.6% |
| Q3 2020 | $871,000 | -40.7% | 293,220 | -7.8% | 0.03% | -42.9% |
| Q2 2020 | $1,469,000 | – | 317,910 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 213,609 | $1,446,000 | 2.75% |
| GABLES CAPITAL MANAGEMENT INC. | 449,164 | $3,041,000 | 1.81% |
| Prairiewood Capital, LLC | 261,403 | $1,770,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 9,572,000 | $64,802,000 | 1.06% |
| Quantedge Capital Pte Ltd | 360,100 | $2,438,000 | 1.03% |
| SummerHaven Investment Management, LLC | 151,384 | $1,025,000 | 0.55% |
| GLOBEFLEX CAPITAL L P | 609,030 | $4,124,000 | 0.42% |
| EAM Global Investors LLC | 347,899 | $2,355,000 | 0.42% |
| Lanham O'Dell & Company, Inc. | 50,000 | $339,000 | 0.27% |
| EAM Investors, LLC | 239,071 | $1,619,000 | 0.27% |